BRPI0413509A - uso de antibióticos de quinolona - Google Patents

uso de antibióticos de quinolona

Info

Publication number
BRPI0413509A
BRPI0413509A BRPI0413509-1A BRPI0413509A BRPI0413509A BR PI0413509 A BRPI0413509 A BR PI0413509A BR PI0413509 A BRPI0413509 A BR PI0413509A BR PI0413509 A BRPI0413509 A BR PI0413509A
Authority
BR
Brazil
Prior art keywords
quinolone antibiotics
antibiotics
quinolone
oral cavity
relates
Prior art date
Application number
BRPI0413509-1A
Other languages
English (en)
Inventor
Gert Daube
Markus Edingloh
Franz Pirro
Agn S Limet
Bernd Stephan
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34201505&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0413509(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of BRPI0413509A publication Critical patent/BRPI0413509A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

"USO DE ANTIBIóTICOS DE QUINOLONA". A presente invenção refere-se ao uso de certos antibióticos de quinolona para controlar doenças bacterianas da cavidade oral, especialmente em medicina veterinária.
BRPI0413509-1A 2003-08-13 2004-08-02 uso de antibióticos de quinolona BRPI0413509A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10337191A DE10337191A1 (de) 2003-08-13 2003-08-13 Neue Verwendung von Chinolon-Antibiotika
PCT/EP2004/008629 WO2005018641A2 (de) 2003-08-13 2004-08-02 Chinolon-antibiotika zur behandlung von periodontalen infektionen

Publications (1)

Publication Number Publication Date
BRPI0413509A true BRPI0413509A (pt) 2006-10-10

Family

ID=34201505

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0413509-1A BRPI0413509A (pt) 2003-08-13 2004-08-02 uso de antibióticos de quinolona

Country Status (32)

Country Link
US (1) US8658645B2 (pt)
EP (1) EP1656143B1 (pt)
JP (2) JP5122814B2 (pt)
KR (1) KR101209119B1 (pt)
CN (1) CN100571702C (pt)
AR (2) AR045093A1 (pt)
AT (1) ATE528004T1 (pt)
AU (2) AU2004266452A1 (pt)
BR (1) BRPI0413509A (pt)
CA (1) CA2535637C (pt)
CY (1) CY1112167T1 (pt)
DE (1) DE10337191A1 (pt)
DK (1) DK1656143T3 (pt)
ES (1) ES2374728T3 (pt)
GT (1) GT200400156A (pt)
HR (1) HRP20120019T1 (pt)
IL (1) IL173655A (pt)
LU (1) LU91883I2 (pt)
MX (1) MXPA06001597A (pt)
MY (1) MY162652A (pt)
NO (1) NO333116B1 (pt)
NZ (1) NZ545261A (pt)
PE (1) PE20050341A1 (pt)
PL (1) PL1656143T3 (pt)
PT (1) PT1656143E (pt)
RU (1) RU2367437C2 (pt)
SI (1) SI1656143T1 (pt)
TW (1) TWI367095B (pt)
UA (1) UA85685C2 (pt)
UY (1) UY28465A1 (pt)
WO (1) WO2005018641A2 (pt)
ZA (1) ZA200601167B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
TW200510425A (en) * 2003-08-13 2005-03-16 Japan Tobacco Inc Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
FR2896416B1 (fr) * 2006-01-24 2010-08-13 Vetoquinol Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine
DE102006010643A1 (de) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006049520A1 (de) 2006-10-20 2008-04-24 Bayer Healthcare Ag Verfahren zur Herstellung von Pradofloxacin
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
WO2010069493A1 (de) * 2008-12-18 2010-06-24 Bayer Animal Health Gmbh Verbesserte wirkstoffkombination enthaltend ein antibiotikum und einen nichtsteroidalen entzündungshemmer (nsaid)
CN102988280B (zh) * 2012-10-08 2014-03-19 新乡医学院 一种加雷沙星滴眼剂
JP6358868B2 (ja) * 2014-06-17 2018-07-18 Ｄｓファーマアニマルヘルス株式会社 オルビフロキサシンを含有する製剤組成物
CN106831795B (zh) * 2017-01-16 2018-12-21 石家庄学院 喹诺酮异土木香内酯衍生物及其制备和应用
US11332444B2 (en) 2018-04-25 2022-05-17 Bayer Animal Health Gmbh Method for the hydrolysis of quinolonecarboxylic esters
US12478621B2 (en) * 2019-11-28 2025-11-25 Deutsches Krebsforschungszentrum Substituted aminoquinolones as dgkalpha inhibitors for immune activation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62205060A (ja) * 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd ８位置換キノロンカルボン酸誘導体
DE3702393A1 (de) * 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
WO1997029102A1 (en) * 1996-02-09 1997-08-14 Toyama Chemical Co., Ltd. Quinolonecarboxylic acid derivatives or salts thereof
EP0882049B1 (de) * 1996-02-23 2002-11-20 Bayer Ag Gegebenenfalls substituierte 8-cyan-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre derivate
TW415943B (en) * 1996-06-28 2000-12-21 Bayer Ag 7-(3-vinyl-1,4-piperazin-1-yl)-substituted quinolonecarboxylic acids
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
DE19652219A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(1-Aminomethyl-2-oxa-7-azabicyclo[3.3.0]oct-7-yl)-chinolon- und naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
WO1999010351A1 (en) * 1997-08-22 1999-03-04 Dainippon Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives and intermediates for the preparation thereof
ATE279193T1 (de) * 1998-11-10 2004-10-15 Bayer Healthcare Ag Pharmazeutische zubereitung von moxifloxacin
DE19962470A1 (de) * 1999-12-22 2001-07-12 Schulz Hans Herrmann Verwendung von Chemotherapeutika
DE10337191A1 (de) * 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika

Also Published As

Publication number Publication date
RU2367437C2 (ru) 2009-09-20
KR20060061353A (ko) 2006-06-07
HK1098687A1 (zh) 2007-07-27
ZA200601167B (en) 2007-04-25
TWI367095B (en) 2012-07-01
MY162652A (en) 2017-06-30
GT200400156A (es) 2005-03-23
DE10337191A1 (de) 2005-03-17
ATE528004T1 (de) 2011-10-15
CA2535637C (en) 2011-11-08
AU2004266452A1 (en) 2005-03-03
AU2011200356B2 (en) 2012-01-12
AU2011200356A1 (en) 2011-02-17
CN1867335A (zh) 2006-11-22
PE20050341A1 (es) 2005-07-07
CN100571702C (zh) 2009-12-23
JP2007501819A (ja) 2007-02-01
SI1656143T1 (sl) 2012-03-30
HRP20120019T1 (hr) 2012-02-29
RU2006107497A (ru) 2006-08-10
AR109644A2 (es) 2019-01-09
US20070082911A1 (en) 2007-04-12
WO2005018641A3 (de) 2005-10-06
WO2005018641A2 (de) 2005-03-03
CA2535637A1 (en) 2005-03-03
NO333116B1 (no) 2013-03-04
JP5122814B2 (ja) 2013-01-16
EP1656143A2 (de) 2006-05-17
LU91883I2 (fr) 2013-04-12
TW200517110A (en) 2005-06-01
NZ545261A (en) 2009-11-27
MXPA06001597A (es) 2006-05-19
JP2012211170A (ja) 2012-11-01
ES2374728T3 (es) 2012-02-21
EP1656143B1 (de) 2011-10-12
PT1656143E (pt) 2012-01-12
PL1656143T3 (pl) 2012-03-30
DK1656143T3 (da) 2012-02-06
NO20061127L (no) 2006-03-08
KR101209119B1 (ko) 2012-12-07
IL173655A (en) 2013-07-31
UA85685C2 (ru) 2009-02-25
IL173655A0 (en) 2006-07-05
UY28465A1 (es) 2005-03-31
AR045093A1 (es) 2005-10-12
US8658645B2 (en) 2014-02-25
CY1112167T1 (el) 2015-12-09

Similar Documents

Publication Publication Date Title
CY1112167T1 (el) Νεα χρηση αντιβιοτικων κινολονης
WO2002047668A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und ciclesonide
WO2002069945A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und pde-iv-inhibitoren
BRPI0417823A (pt) métodos para uso de bifidobactérias probióticas para animais de estimação
AU2003289641A1 (en) The novel coumarin-amide derivatives and its preparation, said drug composition and its use
AR021074A1 (es) COMPOSICIoN FARMACÉUTICA DE MOXIFLOXACINA, PROCEDIMIENTO PARA SU PRODUCCIoN, Y USO DE DICHA COMPOSICIoN PARA PREPARAR UN MEDICAMENTO ANTIBACTERIANO.
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
BR0312728A (pt) Formulação em tablete dispersìvel e processo para sua preparação
AU2002358082A1 (en) Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
DE602005008122D1 (de) Synergistische antibakterielle Formulierung und Herstellungsmethode
ATE454891T1 (de) Geschmacksstoffhaltige arzneimittelformulierungen mit verbesserten pharmazeutischen eigenschaften
WO2004039822A3 (en) 4’’ - modified erythromycin derivatives
HRP20080597T3 (en) Cancer combination therapy comprising azd2171 and zd1839
ATE261732T1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
ATE433459T1 (de) Desoxo-nonadepsipeptide
PT1406859E (pt) Derivados substituídos de 4-aminociclo-hexanol
HRP20080452T3 (hr) Farmaceutski pripravak koji se raspada u ustima isadrži risperidon
ATE455789T1 (de) Substituierte nonadepsipeptide
AU2002238673A1 (en) Human adrenomedullin-specific antibody, pharmaceutical composition containing same, therapeutic uses thereof
WO2002057281A3 (en) Aminoglycosides as antibiotics
DK1497250T3 (da) Hyperforinderivater, anvendelse heraf og sammensætninger indeholdende disse
BRPI0410638A (pt) derivados de azitromicina
WO2002049624A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und dopamin-agonisten
RU2003117895A (ru) Способ местного лечения неспецифических заболеваний эндобронхитов
AU2002237534A1 (en) Remedies for metabolic bone diseases

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER ANIMAL HEALTH GMBH (DE)

Free format text: TRANSFERIDO DE: BAYER HEALTHCARE AG

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]